 BOSTON, Oct. 05, 2021 GLOBE NEWSWIRE -- Albireo Pharma, Inc. Nasdaq: ALBO, a rare pediatric liver disease company developing novel bile acid modulators, joins the PFIC Advocacy and Resource Network PFIC Network in recognition of PFIC Awareness Day 2021, a global effort to support patients and families affected by progressive familial intrahepatic cholestasis PFIC. Established in 2019, PFIC Awareness Day aims to highlight the impact of this disease on patients and families, and to call for new levels of support, including research, advocacy, education and opportunities to connect and share information. 